Tirzepatide (brand name Mounjaro) is a dual-action medication combining GLP-1 and GIP receptor activation, making it effective for weight loss in people across diverse medical backgrounds
Therefore, slowed gastric emptying from the stomach to the upper intestine (duodenum) observed after GLP-1 agonist administration could lead to increased levels of acetaldehyde and an altered or blunted rise in blood alcohol content (BAC)
Typical costs in Europe: 200 to 350 per month for Wegovy 200 to 300 per month for Saxenda 250 to 400 per month for Mounjaro (in countries where approved for weight loss) Prices vary between countries, pharmacies, and based on supply
These conditions are not as common but are key to understanding why people might have blood in their stool
Oral amycretin showed up to 10.1% weight loss Evidence level: Low-moderate -- early-phase data with Lancet publication, impressive trajectories, but small samples and short duration
Altered vasomotor functions have been demonstrated by failed embryo implantation and reduced placental perfusion in preeclampsia and endometriosis
